STAT | Reporting from the frontiers of health and medicine Follow STAT+: Merck suffers a setback in Europe over its new Keytruda formulation In a setback for Merck, a Dutch court ordered a halt to the manufacturing and marketing of a subcutaneous formulation of Keytruda in several European countries. https://www.statnews.com/pharmalot/2026/10/07/merck-suffers-setback-in-europe-over-new-keytruda-formulation/ statnews.com
